AusBiotech 2016 Program

AusBiotech 2016: Monday Sessions
8:00am 

Registration Desk Open

8:00am

 BioIndustry Exhibition Viewing with Tea & Coffee

9:00am - 9:45am

Room 203/204

Welcome to country, IBS 2016 and AusBiotech 2016

Premier of Victoria, The Hon. Daniel Andrews MP

Glenn Cross, CEO, AusBiotech Ltd

Prof Francesco Nicotra, Vice-President of IUPAC Division III, University of Milano-Bicocca, Italy

 

 

 9:45am - 10:30am

100 years old … and just getting started

Chair: Glenn Cross, CEO, AusBiotech Ltd

Paul Perreault, CEO and Managing Director, CSL Ltd

CSL is Australia’s most successful biotech and this year it will spend more than $USD600 million on R&D. CEO Paul Perreault will discuss his decision to locate CSL’s global R&D hub in Melbourne, his vision for a renaissance in Australian 

biotechnology and his view of the elements needed for business success.

 

10:30am-11:00am

Morning Tea & Networking with BioIndustry Exhibitors

 

Concurrent Stream 1
Room 207

Concurrent Stream 2
Room 208

11:00am-12:30pm

New technologies and developments in clinical trials:

Chair: Dr Meera Verma, Acting Chief Executive, TechInSA

Michael Winlo, CEO, Linear Clinical Research Ltd

Luke Edington, Clinical Project Manager, Datapharm

Kieran Connoly, Senior Director APAC Operations, Parexel 

John Moller, COO, Novotech 

National Innovation and Science Agenda Update

Chair: Dr Anna Lavelle, Principal Advisor, AusBiotech Ltd

Bill Ferris AC, Chair, Innovation & Science Australia

Sue MacLeman, Chief Executive Officer, MTP Connect - Medical Technologies and Pharmaceuticals Growth Centre

Peter Chesworth, Head of Division, Innovation Programs, Department of Industry, Innovation and Science

Hank Sciberras, Partner, Tax, Deloitte 

 

 

12:30pm-1:30pm

Lunch & networking with BioIndustry Exhibitors 

12:30pm - 1:15pm 

AusBiotech Annual General Meeting, room 206.

Julie Phillips, Chair, AusBiotech Ltd and the AusBiotech Board invite all members to join the Annual General Meeting, with lunch provided.

 

 

Concurrent Stream 1
Room 207

Concurrent Stream 2
Room 208
1:30pm -3:00pm

Collaboration for innovation - drug development in the modern biopharma era

Chair: Andrew Wear, Director, MedTech and Pharmaceuticals, Department of Economic Development, Jobs, Transport and Resources (DEDJTR) 

Prof Bill Charman, Dean, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University

Dr Warwick Tong, Chief Executive Officer, Cancer Therapeutics CRC (CTX)

Dr Megan Baldwin, Managing Director and Chief Executive Officer, Opthea

Dr MaryJo Chamberlain, Senior Director and Global Head of Academics, Search and Evaluation, AbbVie 

 

Victorian Government Session

 

BioSimilars: The science, the operating environment and the opportunity

Chair: Sean Lybrand, Director, Value Access and Policy, Amgen Australia

Dr Sundar Ramanan, Director, Regulatory and R&D Policy, Amgen

Ric Morgan, Special Counsel, Allens

Frederic Lefebvre, Principal, ANZ, IMS Consulting Group

 

3:00pm - 3:30pm

Afternoon Tea & Networking with BioIndustry Exhibitors

3:30pm - 4:00pm

Room 203 / 204

Announcement of the AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2016

 

4:00pm - 5:00pm

Room 203 / 204

Global update: Key issues facing big pharma globally

Chair: Lorraine Chiroiu, Deputy CEO, AusBiotech Ltd

Dr Stephen Yoder, Head, Speciality Pharmaceuticals Search & Evaluation, BMS Business Development, Bristol-Myers Squibb 

Dr BG Rhee, President, Green Cross Holdings

Dr Reginald Seeto, Head of Partnering and Strategy, MedImmune 

Dr Kevin J. Lynch, Vice President, Search and Evaluation, Abbvie

Sarah Holland, Head of External Science & Partnering, Europe, Sanofi

 

5:00pm - 6:30pm

IBS 2016 and AusBiotech 2016 Welcome Reception

Exhibition hall

Supported by CSL

 

AusBiotech 2016: Tuesday Sessions
7:00am

Registration Desk Open 

6:55am - 7:45am 

South Wharf river promenade precinct walking tour

Hilton Hotel reception - Free to attend - Please RSVP by email: events@ausbiotech.org

Join us for a walking tour that highlights Melbournes discovery and exploration,  waterfront history, initial settlement and Aboriginal history. Tour will include Melbourne maps, bushtucker samples, historic souvenir and chocolate sample 

7:30am - 8:30am

MasterControl Business Breakfast: How to make life changing products available to more people sooner.

Presenter: Chad Fox - President of MasterControl Asia

Join us and experience our version of MasterControl quality management. You will see first hand the essence of our mission statement; To make life changing products available to more people sooner.

*Invitation only

 

8:30am

BioIndustry Exhibition Open

8:45am - 10:30am

Room 203/204

Chair: Glenn Cross, CEO, AusBiotech Ltd

Biotechnology and innovation: risk and precaution - social license or not?
Sir Peter Gluckman,
Chief Science Advisor to the Prime Minister, Office of the Prime Minister, New Zealand

 

Millis Oration 

Introduction: Dr Andrea Douglas, Vice President R&D Strategy, CSL
Prof Ian Gust, Professorial Fellow, University of Melbourne

 

 

Johnson & Johnson Innovation – JJDC:  Bringing Smart Money to Your Business

Dr Jeanne Bolger, Vice President Venture Investments, Johnson & Johnson Innovation 

 

10:30am - 11:00am

Morning tea and networking with BioIndustry Exhibitors

 

Concurrent Stream 1 

Room 207

Concurrent Stream 2 

Room 208

Concurrent Stream 3

Room 209

11:00 - 12:30pm

Recent developments in Australian and US patent law in the life sciences industry, including post-grant proceedings

Introduction: Jenny Petering, Of Counsel, FB Rice

Chair: Dr Lisa Haile, Partner, DLA Piper

Nicholas Tyacke, Partner, DLA Piper

Geraldine Farrell, General Counsel & Vice President Operations, Nexvet Biopharma plc

Patrick McManamny, Partner, FB Rice

 

Establishing better links between industry and research institutes

Chair: Dr Julian Chick, Chief Operating Officer, Admedus Limited

Julian Clarke, Head, Business Development, WEHI

James Dromey, Head of Commercialisation & Legal, Murdoch Childrens Research Institute

Dr Keith McLean, Director, Manufacturing Flagship, CSIRO  

Bill McKeon, COO/Chief strategy development officer, Texas Medical Centre innovation

The Key to Successful Tech Transfer and Flexible Bio-manufacturing Service

Chair – David Hughes, CEO, BioPharmaceuticals Australia 

Dr Evan Shave, Process Engineering & Validation Manager, Patheon Biologics

Chris Behrenbruch, CEO, Red Hill Pharmaceuticals

Dianne Jackson-Matthews, Director of Regulatory Affairs, ERA Consulting

 

 

12:30 - 1:30pm

Lunch & networking with BioIndustry Exhibitors

 

Concurrent Stream 1 

Room 207

Concurrent Stream 2 

Room 208

 Concurrent Stream 3

Room 209

1:30 - 3:00pm

Global BioPolicy

Chair: Dr Anna Lavelle, Principal Advisor, AusBiotech Ltd

Andrew Casey, President & CEO, BIOTECanada

Dr Viola Bronsema, CEO & Secretary General, BIO Deutschland, Germany

Barry Heavey, Head of Life Sciences, Engineering & Industrial Tech, IDA Ireland

The future of the Australian regenerative medicine sector 

Introduction: Silvio Tiziani, Chief Operating Officer, Australian Regenerative Medicine Institute & Executive Director, EMBL Australia

Speaker: Professor Martin Pera, Chair, Stem Cell Sciences, University of Melbourne

Followed by Q&A panel:

Chair: Assoc Professor Megan Munsie, Head-Education, Ethics, Law & Community Awareness Unit, Stem Cells Australia

Panellists:

Paul Anderson, Chief Executive Officer, Orthocell

Sue MacLeman, Chief Executive Officer, MTPConnect Ltd

Tim Oldham, Chief Executive Officer, Cell Therapies Pty Ltd

Dr Damian Bates, Chief Medical Officer and Head of Research, SanBio

Dr Amanda Caples, Lead Scientist, Victorian State Government

Cyber risks for life science companies

Travis McIntosh, Assistant VP, Life Science Specialist, Asia Pacific Zone Chubb

Shane Aitken, Chief Operating Officer, Avatar Brokers Pty Ltd

Warren Dunn, Partner, EY Fraud Investigation & Dispute Services

Katherine Hayes, Senior Associate, Carter Newell Lawyers

 

3:00 - 3:30pm

Afternoon tea & networking with BioIndustry Exhibitors

3:30 - 5:00pm

Room 203/204

Early stage Life Sciences Investment - Global Perspective

 

Chair: Lawrence Gozlan, CEO, Scientia Capital

Jeremy Curnock Cook, Managing Director and Executive Chairman, BioScience Managers

Warren Dunnavant, Director Healthcare Investment Banking, ROTH Capital

Dr Andrew Kelly, Executive Director, BioPacific Partners

Hershell Berry, Managing Partner, Blueprint

 

7:00 - 11:00pm

International Biofest 2016 Conference dinner, Docklands
Peninsula – Atlantic Group, Shed 14 Central Pier

Supported by Patheon

            

AusBiotech 2016: Wednesday Sessions
8:00am

Registration Desk & BioIndustry Opens

10:00am - 3:00pm

BioIndustry Exhibition Hall Trade Day

9:30 - 10:30am

Room 203/204

Successful commercialisation of life science research

Chair: Dr Anna Lavelle, Principal Advisor, AusBiotech Ltd

Hugh Alsop, CEO, Hatchtech Pty Ltd

Prof Darren Kelly, CEO & Managing Director, OccuRx Pty Ltd

Dr Dean Moss, CEO, UniQuest Pty Ltd

Dr Megan Baldwin, CEO & Managing Director, Opthea

 

10:30am - 11:00am

Morning tea and networking with BioIndustry Exhibitors 

11:00am - 11:30am

Room 203/204

Chair: Glenn Cross, CEO, AusBiotech Ltd

Collaborations between institution, how to grow a world class collaborative medical centre

Robert Robbins, President, Texas Medical Centre

 

11:30am - 12:00pm

Update on the UK Life Science Sector

Dr Jon Mowles, Life Sciences Specialist, UK Department for International Trade

12:00pm - 12:30pm 

The Science of Swisse

Radek Sali, Chief Executive Officer, Swisse Wellness Pty Ltd

 

12:30pm - 1.30pm

Lunch and networking with BioIndustry Exhibitors

12:30pm - 1:30pm

Room 208

UK Department for International Trade lunch - Discover Opportunities in UK Life Sciences

Invitation only, express interest: events@ausbiotech.org

A panel of Life Sciences experts from the UK and Australia will explore the opportunities for business and research collaboration in the UK. 

      

 

 

Room 206

IDA- Ireland Business Lunch: Biomanufacturing strategies for the future

Invitation only, express interest:  events@ausbiotech.org

Hear from Barry Heavey, Global Head of Life Sciences at IDA Ireland about the latest biomanufacturing advancements and opportunities for business, research and collaboration in Ireland.

 

1:40pm - 2:00pm

Room 203/204

Reflecting on the AusBiotech Strategic Plan 2013 - 2016 and looking to the future

Chair: Michelle Burke, Director, External Affairs, Bristol-Myers Squib

Julie Phillips, Chair, Ausbiotech Ltd

2:00pm - 2:20pm

Transformation, Developments, Opportunities and Future of Global CRO Market

Sanjeev Kumar, Industry Manager, Transformational Health: Life sciences, Frost & Sullivan

2:20pm - 3:00pm

Nanoparticles for therapy and diagnosis of Alzheimer Disease – A European Union example of translation of academic results

Prof Francesco Nicotra, Vice-President of IUPAC Division III, University of Milano-Bicocca, Italy

3:00pm - 3:45pm

Afternoon tea and networking with BioIndustry Exhibitors 

3:45pm - 4:30pm

Room 203/204

European Life Science Industry Update

Dr Viola Bronsema, Secretary General and CEO, BIO Deutschland

4:30pm - 4:45pm

AusBiotech 2016 Closing and handover to AusBiotech 2017

Glenn Cross, Chief Executive Officer, AusBiotech Ltd

The Hon Kyam Maher MLC, Minister for Science and Information Economy, Government of South Australia

 

4:45pm - 6.00pm

International BioFest Networking Reception, networking for all three BioFest events, canapes, drinks, live entertainment and networking

Supported by the Department of Industry, Innovation and Science

Showtime Events Centre, South Wharf precinct